Andromeda Surgical
New accelerator entry · 2023-05-19 · the record
We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects.
Andromeda Surgical is a Y Combinator company in the Summer 2023 batch. Its directory entry describes it as: Autonomous surgical robots. The founders listed are Nick Damiano (Founder), Kartik Tiwari (Founder) (Y Combinator directory entry, May 19, 2023).
Sell to companies like Andromeda Surgical? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2023-05-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Andromeda Surgical.
Free to see. No signup.
More on Andromeda Surgical and the records around it.
Same batch, Healthcare first.
Get an email when Andromeda Surgical changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Andromeda Surgical raises, hires or launches. No email unless you switch it on.
Watch Andromeda Surgical →Get the full cited report on Andromeda Surgical
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Andromeda Surgical: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Andromeda Surgical: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Andromeda Surgical covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Andromeda SurgicalYou get an alert in MentionFox the next time this company shows up.
If you're behind Andromeda Surgical: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Andromeda Surgical. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.

https://mentionfox.com/funding/yc-andromeda-surgical